Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Guilford, Connecticut 25 trials found
New Search
Filter
Trial Phase
Study Type
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Project: Every Child for Younger Patients With Cancer
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
PHASE2, PHASE3INTERVENTIONAL Hot Springs, Arkansas +4 more
RECRUITING
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
PHASE2INTERVENTIONAL New Haven, Connecticut
RECRUITING
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
N/AOBSERVATIONAL Duarte, California +4 more
RECRUITING
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
PHASE2INTERVENTIONAL Orange, California +4 more
RECRUITING
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
NAINTERVENTIONAL New Haven, Connecticut +1 more
RECRUITING
The DRAGON 2 Trial
NAINTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
PHASE1INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
The Cancer of the Pancreas Screening-5 CAPS5)Study
PHASE3INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
N/AOBSERVATIONAL Mesa, Arizona +4 more
RECRUITING
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
PHASE1, PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
PHASE1, PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type